CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $6,669,998
- in 2 filings, $6.7M under 10b5-1 plans
Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-05 | BATE KENNETH Director | Option exercise | +5,470 | $9.45 | $52K | 8,097 |
| 2025-11-05 | BATE KENNETH Director | Option exercise | +10,000 | $303.79 | $3.0M | 18,097 |
| 2025-11-05 | BATE KENNETH Director | Option exercise | +1,105 | $280.04 | $309K | 19,202 |
| 2025-11-05 | BATE KENNETH Director | Sale | −1,763 | $480.24 | $847K | 17,439 |
| 2025-11-05 | BATE KENNETH Director | Sale | −3,259 | $481.13 | $1.6M | 14,180 |
| 2025-11-05 | BATE KENNETH Director | Sale | −1,284 | $482.41 | $619K | 12,896 |
| 2025-11-05 | BATE KENNETH Director | Sale | −2,069 | $483.41 | $1.0M | 10,827 |
| 2025-11-05 | BATE KENNETH Director | Sale | −1,931 | $484.78 | $936K | 8,896 |
| 2025-11-05 | BATE KENNETH Director | Sale | −1,008 | $485.54 | $489K | 7,888 |
| 2025-11-05 | BATE KENNETH Director | Sale | −827 | $486.73 | $403K | 7,061 |
| 2025-11-05 | BATE KENNETH Director | Sale | −2,775 | $487.49 | $1.4M | 4,286 |
| 2025-11-05 | BATE KENNETH Director | Sale | −696 | $489.09 | $340K | 3,590 |
| 2025-11-05 | BATE KENNETH Director | Sale | −933 | $489.95 | $457K | 2,657 |
| 2025-11-05 | BATE KENNETH Director | Sale | −30 | $490.98 | $15K | 2,627 |
| 2025-11-05 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −5,470 | 0 | ||
| 2025-11-05 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2025-11-05 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −1,105 | 0 | ||
| 2025-08-15 | BATE KENNETH Director | Option exercise | +10,000 | $16.46 | $165K | 12,627 |
| 2025-08-15 | BATE KENNETH Director | Sale | −2,317 | $363.41 | $842K | 10,310 |
| 2025-08-15 | BATE KENNETH Director | Sale | −2,516 | $364.24 | $916K | 7,794 |
Page 1 of 4 · 78 trades